Brainsway Stock Analysis

BRSYF Stock  USD 8.53  0.00  0.00%   
BrainsWay is overvalued with Real Value of 7.18 and Hype Value of 8.53. The main objective of BrainsWay pink sheet analysis is to determine its intrinsic value, which is an estimate of what BrainsWay is worth, separate from its market price. There are two main types of BrainsWay's stock analysis: fundamental analysis and technical analysis.
The BrainsWay pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and BrainsWay's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BrainsWay. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more detail on how to invest in BrainsWay Pink Sheet please use our How to Invest in BrainsWay guide.

BrainsWay Pink Sheet Analysis Notes

About 20.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.61. Some equities with similar Price to Book (P/B) outperform the market in the long run. BrainsWay recorded a loss per share of 0.22. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 23rd of May 2011. Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 118 people.The quote for BrainsWay is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on BrainsWay please contact Christopher Jako at 972 2 582 4030 or go to https://www.brainsway.com.

BrainsWay Investment Alerts

BrainsWay is way too risky over 90 days horizon
BrainsWay appears to be risky and price may revert if volatility continues
The company reported the revenue of 29.66 M. Net Loss for the year was (6.46 M) with profit before overhead, payroll, taxes, and interest of 24.35 M.
About 20.0% of the company shares are held by company insiders

BrainsWay Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.72 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BrainsWay's market, we take the total number of its shares issued and multiply it by BrainsWay's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

BrainsWay Profitablity

The company has Profit Margin (PM) of (0.37) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.29) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.29.

Technical Drivers

As of the 25th of December, BrainsWay shows the mean deviation of 5.1, and Risk Adjusted Performance of 0.108. BrainsWay technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BrainsWay risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis to decide if BrainsWay is priced correctly, providing market reflects its regular price of 8.53 per share. Given that BrainsWay has variance of 441.98, we suggest you to validate BrainsWay's prevailing market performance to make sure the company can sustain itself at a future point.

BrainsWay Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BrainsWay middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BrainsWay. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

BrainsWay Predictive Daily Indicators

BrainsWay intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BrainsWay pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

BrainsWay Forecast Models

BrainsWay's time-series forecasting models are one of many BrainsWay's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BrainsWay's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About BrainsWay Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how BrainsWay prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BrainsWay shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as BrainsWay. By using and applying BrainsWay Pink Sheet analysis, traders can create a robust methodology for identifying BrainsWay entry and exit points for their positions.
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 118 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding BrainsWay to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Complementary Tools for BrainsWay Pink Sheet analysis

When running BrainsWay's price analysis, check to measure BrainsWay's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrainsWay is operating at the current time. Most of BrainsWay's value examination focuses on studying past and present price action to predict the probability of BrainsWay's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrainsWay's price. Additionally, you may evaluate how the addition of BrainsWay to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device